Distinguishing benign and malignant thyroid nodules using plasma trimethylamine N-oxide, carnitine, choline and betaine
Journal of Cancer Research and Clinical Oncology · 2024
DOI: 10.1007/s00432-024-05666-w ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cancer Research and Clinical Oncology, 2024. Verfasst von Liang Shi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210006, China. Hauptthemen laut MEDLINE: Betaine, Thyroid Nodule, Methylamines. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The China Postdoctoral Science Foundation, Nanjing Health Science and Technology Development Project, National Natural Science Foundation of China.
Abstract (Originalsprache)
Purpose
Trimethylamine N-oxide (TMAO), a gut microbiome–derived metabolite, and its precursors (carnitine, choline, betaine) have not been fully examined in relation to thyroid cancer (TC) risk. The aim of this study was to assess the value of TMAO and its precursors in diagnosis of benign and malignant thyroid nodules.
Methods
In this study, high-performance liquid chromatography-tandem mass spectrometry was utilized to measure the levels of plasma TMAO and its precursors (choline, carnitine, and betaine) in 215 TC patients, 63 benign thyroid nodules (BTN) patients and 148 healthy controls (HC). The distribution of levels of TMAO and its precursors among the three groups were compared by the Kruskal–Wallis test. Receiver operating characteristic curve (ROC) analysis was performed to evaluate the sensitivity, specificity, and the predictive accuracy of single and combined biomarkers.
Results
In comparison to HC, TC showed higher levels of TMAO and lower levels of its precursors (carnitine, choline, and betaine) (all P < 0.001). Plasma choline ( P < 0.01) and betaine ( P < 0.05) were declined in BTN than HC. The levels of carnitine ( P < 0.001) and choline ( P < 0.05) were significantly higher in BTN than that in TC group. Plasma TMAO showed lower levels in TC with lymph node metastasis (101.5 (73.1–144.5) ng/ml) than those without lymph node metastasis (131 (84.8–201) ng/ml, P < 0.05). Combinations of these four metabolites achieved good performance in the differential diagnosis, with the area under the ROC curve of 0.703, 0.741, 0.793 when discriminating between TC and BTN, BTN and HC, TC and HC, respectively.
Conclusion
Plasma TMAO, along with its precursors could serve as new biomarkers for the diagnosis of benign and malignant thyroid nodules.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210006, China.
- Department of General Surgery, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210006, China.
- Department of Health Management Center, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210006, China.
- Department of Endocrinology, Nanjing First Hospital, Nanjing, 210006, China.
- Department of Nuclear Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210006, China. fengwangcn@hotmail.com.
- Department of Nuclear Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210006, China. xuexue@njmu.edu.cn.
Förderung
- The China Postdoctoral Science Foundation
- Nanjing Health Science and Technology Development Project
- National Natural Science Foundation of China
- Jiangsu Provincial Medical Key Discipline Cultivation Unit
- Jiangsu Province Research Hospital Cultivation Unit
- Medical Science and Technology Program of Nanjing
Zitieren
APA
Shi, L., Guo, M., Shi, C., Gao, G., Xu, X., Zhang, C., Fu, J., Ni, Y., Wang, F., Xue, X., & Yu, F. (2024). Distinguishing benign and malignant thyroid nodules using plasma trimethylamine N-oxide, carnitine, choline and betaine. Journal of Cancer Research and Clinical Oncology. https://doi.org/10.1007/s00432-024-05666-w
Vancouver
Shi L, Guo M, Shi C, Gao G, Xu X, Zhang C, et al. Distinguishing benign and malignant thyroid nodules using plasma trimethylamine N-oxide, carnitine, choline and betaine. Journal of Cancer Research and Clinical Oncology. 2024. doi:10.1007/s00432-024-05666-w
BibTeX
@article{Shi2024,
author = {Shi, Liang and Guo, Muhong and Shi, Cuixiao and Gao, Gu and Xu, Xianghong and Zhang, Chuan and Fu, Jingjing and Ni, Yudan and Wang, Feng and Xue, Xue and Yu, Fei},
title = {Distinguishing benign and malignant thyroid nodules using plasma trimethylamine N-oxide, carnitine, choline and betaine},
journal = {Journal of Cancer Research and Clinical Oncology},
year = {2024},
doi = {10.1007/s00432-024-05666-w}
}
EUVIMED